Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Catheter Directed Thrombolytic Therapy for Pediatric Cerebral Sinus Vein Thrombosis

Marcela Torres, MD, Tyler Hamby, PhD, Sarah Philip, MDcal Student, Jo Ann Tilley, DNP, APRN, CPNP

Blood (2019) 134 (Supplement_1): 3666.

https://doi.org/10.1182/blood-2019-132082

Published: 2019

Journal Articles

Development of a Clinical Prediction Rule for the Risk of Venous Thromboembolism in Patients with Acute Leukemia

Fatimah Al-Ani, MD MRCP, Yimin Pearl Wang, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2018) 132 (Supplement 1): 2223.

https://doi.org/10.1182/blood-2018-99-117405

Published: 2018

Journal Articles

Quantitative Sensory Testing in Children with Sickle Cell Disease

Robin E Miller, MD, Dawn S Brown, PCNS,FNP,CCRC, Sarah E Hegarty, MPhil, Scott W Keith, PhD, Benjamin E Leiby, PhD, Yamaja Setty, PhD, Suhita Gayen-Betal, PhD, Claudia M Campbell, PhD, Marie Stuart, MD

Blood (2017) 130 (Supplement 1): 3541.

https://doi.org/10.1182/blood.V130.Suppl_1.3541.3541

Published: 2017

Journal Articles

Outcomes and Risk Factors Associated with Thrombosis Recurrence and Post-Thrombotic Syndrome in Children and Adolescents with May-Thurner Syndrome

Michael H. White, MD, Brandon M. Cramer, MD, Anne E. Gill, MD, C. Matthew Hawkins, MD, Kavita N. Patel, MD MS

Blood (2017) 130 (Supplement 1): 3417.

https://doi.org/10.1182/blood.V130.Suppl_1.3417.3417

Published: 2017

Journal Articles

Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis: Experience from a Canadian Thrombosis Referral Centre

Andrea Charron, MSc, MD, Neal Manning, MDBSc,FRCPC, James Douketis, MD FRCPC

Blood (2017) 130 (Supplement 1): 4922.

https://doi.org/10.1182/blood.V130.Suppl_1.4922.4922

Published: 2017

Journal Articles

Systematic Review of Treatment for Massive and Submassive Pulmonary Embolism

Shipa Gupta, MD, Esteban Gandara, MD MSc, FRCPC, Marc Carrier, MD MSc, FRCPC, Lana A Castellucci, MD MSc, FRCPC

Blood (2016) 128 (22): 2612.

https://doi.org/10.1182/blood.V128.22.2612.2612

Published: 2016

Journal Articles

Allogeneic Stem Cell Transplantation From Matched Related Donor in Patients Over the Age of 55 Years: A Prospective Multicenter Phase II Study of a Reduced Intensity Conditioning Associating Fludarabin-IV Busulfan and Thymoglobulin

Didier Blaise, MD, Mohamad Mohty, Noel Milpied, MD, Anne Gaelle Lecorroller, PhD, Nathalie Fegueux, Sabine Furst, MD, Patrice Chevallier, MD, Reza Tabrizi, MD, Mauricette Michallet, MD, PhD, Jean Yves Cahn, MD, Anne Sirvent, MD, Jacques-Olivier Bay, MD, PhD, Jean El Cheikh, MD, PhD, Catherine Faucher, MD, Roberto Crocchiolo, MD, Agnes Boyer-Chamard, MD, Luca Castagna, MD, Jean Marie Boher, PhD

Blood (2011) 118 (21): 1952.

https://doi.org/10.1182/blood.V118.21.1952.1952

Published: 2011

Journal Articles

Treatment Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Pre-Clinical AML and DLBCL Models

Michael Milhollen, Michael Thomas, Tary Traore, Usha Narayanan, Jessica Riceberg, Todd Sells, PhD, Ben Amidon, PhD, Mark Manfredi, PhD, Neil Bence, PhD, James Brownell, PhD, Larry Dick, PhD, Erik Koenig, James Gavin, Peter G Smith, PhD

Blood (2011) 118 (21): 1413.

https://doi.org/10.1182/blood.V118.21.1413.1413

Published: 2011

Journal Articles

Comparison of Clostridium Difficile Associated Diarrhea Detection by Enzyme Linked Immunosorbent Assay (EIA) and Polymerase Chain Reaction (PCR) in Autologous Hematopoietic Stem Cell Transplant (AHSCT) Recipients

Kenneth Utz, Pharm.D., BCOP, Christopher Frei, PharmD, MS, BCPS, Bonita Neumon, MPAS, Brenda L. Frye, MPAS, DHSc, Deanna Schneider, David J Haile, MD, Cesar O. Freytes, MD

Blood (2011) 118 (21): 4739.

https://doi.org/10.1182/blood.V118.21.4739.4739

Published: 2011

Journal Articles

Improved Functional Outcome After Additional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Results of a Randomized Controlled Clinical Trial (The CaVenT Study)

Tone Rønnaug Enden, MD, PhD, Ylva Haig, MD, Nils-Einar Kløw, MD, PhD, Carl Erik Slagsvold, MD, PhD, Leiv Sandvik, PhD, Waleed Ghanima, MD, PhD, Geir Hafsahl, MD, PhD, Pål Andre Holme, MD, PhD, Lars Olaf Holmen, MD, Anne Mette Njaastad, MD, Gunnar Sandbaek, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2011) 118 (21): LBA-1.

https://doi.org/10.1182/blood.V118.21.LBA-1.LBA-1

Published: 2011

Journal Articles

Phase 1 Dose-Escalation Study of Multiple Dosing Schedules of the Investigational Drug MLN4924, a Nedd8-Activating Enzyme Inhibitor, In Patients with Relapsed and/or Refractory Multiple Myeloma or Lymphoma.

Jatin J Shah, MD, R. Donald Harvey, PharmD, Owen A O'Connor, MD, PhD, Andrzej J Jakubowiak, MD, PhD, Mitchell R Smith, MD, PhD, Robert Z. Orlowski, MD, PhD, George J Mulligan, PhD, Peter G Smith, PhD, Michael D Pickard, MA, Bruce J. Dezube, MD, Sagar Lonial, MD

Blood (2010) 116 (21): 2801.

https://doi.org/10.1182/blood.V116.21.2801.2801

Published: 2010

Journal Articles

Phase 1 Dose-Escalation Study of MLN4924, a Novel NAE Inhibitor, in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.

Jatin J Shah, Andrzej J Jakubowiak, Owen A O’Connor, Robert Z Orlowski, Molly Patterson, Donald Harvey, Allison J Berger, Alice McDonald, George Mulligan, Lilli Petruzzelli, Michael D Pickard, Peter G Smith, Karthik Venkatakrishnan, Sagar Lonial

Blood (2009) 114 (22): 1854.

https://doi.org/10.1182/blood.V114.22.1854.1854

Published: 2009

Journal Articles

MLN4924, A Novel First in Class Small Molecule Inhibitor of the Nedd8 Activating Enzyme (NAE), Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia.

Ronan T. Swords, M.D., Kevin R. Kelly, MD, Peter G. Smith, PhD, James J. Gansey, Devalingam Mahalingam, M.D., Swaminathan Padmanabhan, MD, MBBS, Michael C. O'Dwyer, MD, FRCPI, FRCPath, Steffan T. Nawrocki, PhD, Francis J. Giles, MD, Jennifer S. Carew, Ph.D.

Blood (2009) 114 (22): 1021.

https://doi.org/10.1182/blood.V114.22.1021.1021

Published: 2009

Journal Articles

Adjunctive Catheter-Directed Venous Thrombolysis in Iliofemoral Deep Vein Thrombosis; Short-Term Results from the CaVenT Study, a Multicenter Randomized Controlled Trial

Tone Rønnaug Enden, MD, Carl-Erik Slagsvold, MD, PhD, Nils-Einar Kløw, MD, PhD, Per Morten Sandset, MD, PhD

Blood (2008) 112 (11): 989.

https://doi.org/10.1182/blood.V112.11.989.989

Published: 2008

Journal Articles

Efficacy of Risk Adapted Cyclophosphamide, Thalidomide and Dexamethasone in Systemic AL Amyloidosis.

Ashutosh D. Wechalekar, Hugh J.B. Goodman, Julian D. Gillmore, Helen J. Lachmann, Mark Offer, Arthur R. Bradwell, Philip N. Hawkins

Blood (2005) 106 (11): 3496.

https://doi.org/10.1182/blood.V106.11.3496.3496

Published: 2005

NARROW

Catheter Directed Thrombolytic Therapy for Pediatric Cerebral Sinus Vein Thrombosis

Development of a Clinical Prediction Rule for the Risk of Venous Thromboembolism in Patients with Acute Leukemia

Quantitative Sensory Testing in Children with Sickle Cell Disease

Outcomes and Risk Factors Associated with Thrombosis Recurrence and Post-Thrombotic Syndrome in Children and Adolescents with May-Thurner Syndrome

Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis: Experience from a Canadian Thrombosis Referral Centre

Systematic Review of Treatment for Massive and Submassive Pulmonary Embolism

Allogeneic Stem Cell Transplantation From Matched Related Donor in Patients Over the Age of 55 Years: A Prospective Multicenter Phase II Study of a Reduced Intensity Conditioning Associating Fludarabin-IV Busulfan and Thymoglobulin

Treatment Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Pre-Clinical AML and DLBCL Models

Comparison of Clostridium Difficile Associated Diarrhea Detection by Enzyme Linked Immunosorbent Assay (EIA) and Polymerase Chain Reaction (PCR) in Autologous Hematopoietic Stem Cell Transplant (AHSCT) Recipients

Improved Functional Outcome After Additional Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Results of a Randomized Controlled Clinical Trial (The CaVenT Study)

Phase 1 Dose-Escalation Study of Multiple Dosing Schedules of the Investigational Drug MLN4924, a Nedd8-Activating Enzyme Inhibitor, In Patients with Relapsed and/or Refractory Multiple Myeloma or Lymphoma.

Phase 1 Dose-Escalation Study of MLN4924, a Novel NAE Inhibitor, in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.

MLN4924, A Novel First in Class Small Molecule Inhibitor of the Nedd8 Activating Enzyme (NAE), Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia.

Adjunctive Catheter-Directed Venous Thrombolysis in Iliofemoral Deep Vein Thrombosis; Short-Term Results from the CaVenT Study, a Multicenter Randomized Controlled Trial

Efficacy of Risk Adapted Cyclophosphamide, Thalidomide and Dexamethasone in Systemic AL Amyloidosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only